The topography of DNA methylation in the non-neoplastic colonic mucosa surrounding colorectal cancers

Molecular Carcinogenesis

Volumn 53, Issue 2, 2014, Pages 98-108

  Subramaniam, Manish Mani ^a,b   Loh, Marie ^b   Chan, Jason Yongsheng ^b   Liem, Natalia ^a   Lim, Pei Li ^a   Peng, Yong Wei ^a   Lim, Xn Yii ^b   Yeoh, Khay Guan ^a   Iacopetta, Barry ^c   Soong, Richie ^a,b   Salto Tellez, Manuel ^a,b,d  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Colorectal cancer; Colorectal field; DNA methylation; Field effect; Non neoplastic mucosa

Indexed keywords

B RAF KINASE; BETA ACTIN; BONE MORPHOGENETIC PROTEIN 2; K RAS PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR RUNX3;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER TISSUE; CASE REPORT; COLON MUCOSA; COLON TUMOR; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; HEMICOLECTOMY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; NON NEOPLASTIC COLONIC MUCOSA; PRIORITY JOURNAL; TUMOR VOLUME; VERY ELDERLY;

COLORECTAL CANCER; COLORECTAL FIELD; DNA METHYLATION; FIELD EFFECT; NON-NEOPLASTIC MUCOSA;

AGED; COLON; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED;

EID: 84892842111     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21951     Document Type: Article

References (58)

1. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319:525-532.
2. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-767.
3. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008; 135:1079-1099.
4. Goel A, Nagasaka T, Arnold CN, et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007; 132:127-138.
5. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50:113-130.
6. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002; 123:862-876.
7. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004; 53:1137-1144.
8. Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006; 38:787-793.
9. Shen L, Toyota M, Kondo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 2007; 104:18654-18659.
10. Spring KJ, Zhao ZZ, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: A prospective study of patients undergoing colonoscopy. Gastroenterology 2006; 131:1400-1407.
11. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7:536-540.
12. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998; 58:5489-5494.
13. Nakagawa H, Nuovo GJ, Zervos EE, et al. Age-related hypermethylation of the 50 region of MLH1 in normal colonic mucosa is associated with microsatelliteunstable colorectal cancer development. Cancer Res 2001; 61:6991-6995.
14. Worthley DL, Whitehall VL, Buttenshaw RL, et al. DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene 2010; 29:1653-1662.
15. Kawakami K, Ruszkiewicz A, Bennett G, et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 2006; 94:593-598.
16. Menigatti M, Truninger K, Gebbers JO, Marbet U, Marra G, Schär P. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene 2009; 28:899-909.
17. Belshaw NJ, Elliott GO, Foxall RJ, et al. Profiling CpG island field methylation in both morphologically normal and neoplastic human colonic mucosa. Br J Cancer 2008; 99:136-142.
18. Horii J, Hiraoka S, Kato J, et al. Age-related methylation in normal colon mucosa differs between the proximal and distal colon in patients who underwent colonoscopy. Clin Biochem 2008; 41:1440-1448.
19. Figueiredo JC, Grau MV, Wallace K, et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009; 18:1041-1049.
20. Choi SW, Mason JB. Folate status: Effects on pathway of colorectal carcinogenesis. J Nutr 2002; 132:28S.
21. Kim YI. Folate and DNA methylation: A mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004; 13:511-519.
22. Pufulete M, Al-Ghnaniem R, Leather AJ, et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: A case control study. Gastroenterology 2003; 124:1240-1248.
23. Pufulete M, Al-Ghnaniem R, Khushal A, et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005; 54:648-653.
24. Pufulete M, Al-Ghnaniem R, Rennie JA, et al. Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. Br J Cancer 2005; 92:838-842.
25. Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Watanabe G, Iacopetta B. The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductase. Clin Cancer Res 2003; 9:5860-5865.
26. Iacopetta B, Grieu F, Phillips M, et al. Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa. Cancer Sci 2007; 98:1454-1460.
27. Friso S, Choi SW, Girelli D, et al. A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002; 76:5606-5610.
28. Paz MF, Avila S, Fraga MF, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 2002; 62:4519-4524.
29. Chen J, Kyte C, Valcin M, et al. Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 2004; 110:617-620.
30. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: A HuGE review. Am J Epidemiol 2004; 159:423-443.
31. Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005; 97:1330-1338.
32. Hawkins NJ, Lee JH, Wong JJ, Kwok CT, Ward RL, Hitchins MP. MGMT methylation is associated primarily with the germline C>T SNP (rs 16906252) in colorectal cancer and normal colonic mucosa. Mod Pathol 2009; 22:1588-1599.
33. Gonzalo V, Lozano JJ, Muñoz J, et al. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. PLoS ONE 2010; 5:e8777.
34. Giovannucci E, Ogino S. DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 2005; 97:1317-1319.
35. Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36:417-422.
36. Minoo P, Baker K, Goswami R, et al. Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 2005; 55:1467-1474.
37. Ye C, Shrubsole MJ, Cai Q, et al. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep 2006; 16:429-435.
38. Ally MS, Al-Ghnaniem R, Pufulete M. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors. Cancer Epidemiol Biomarkers Prev 2009; 18:922-928.
39. Hiraoka S, Kato J, Horii J, et al. Methylation status of normal background mucosa is correlated with occurrence and development of neoplasia in the distal colon. Hum Pathol 2010; 41:38-47.
40. Ang PW, Toh HB, Iacopetta B, Soong R. An improved quality control for bisulfite-PCR-based DNA methylation analysis: Cycle threshold value. Clin Chem Lab Med 2008; 46:1117-1121.
41. Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Iacopetta B. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer 2006; 5:2.
42. Wang C, van Rijnsoever M, Grieu F, et al. Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer. Oncology 2003; 64:259-265.
43. Gross E, Kiechle M, Arnold N. Mutation analysis of p53 in ovarian tumours by DHPLC. J Biochem BiophysMethods 2001; 47:73-81.
44. Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002; 34:541-547.
45. Bibikova M, Fan JB. GoldenGate assay for DNA methylation profiling. Methods Mol Biol 2009; 507:149-163.
46. Ang PW, Loh M, Liem N, et al. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 2010; 10:227.
47. Zhang D, Bai Y, Ge Q, et al. Microarray-based molecular margin methylation pattern analysis in colorectal carcinoma. Anal Biochem 2006; 355:117-124.
48. Ramírez N, Bandrés E, Navarro A, et al. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions. Eur J Cancer 2008; 44:2689-2695.
49. Funakoshi S, Ezaki T, Kong J, Guo RJ, Lynch JP. Repression of the desmocollin 2 gene expression in human colon cancer cells is relieved by the homeodomain transcription factors Cdx1 and Cdx2. Mol Cancer Res 2008; 6:1478-1490.
50. Wang Y, Hung C, Koh D, Cheong D, Hooi SC. Differential expression of Hox A5 in human colon cancer cell differentiation: A quantitative study using real-time RT-PCR. Int J Oncol 2001; 18:617-622.
51. Kanai M, Hamada J, Takada M, et al. Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas. Oncol Rep 2010; 23:843-851.
52. Belshaw NJ, Pal N, Tapp HS, et al. Patterns of DNA methylation in individual colonic crypts reveal aging and cancer-related field defects in the morphologically normal mucosa. Carcinogenesis 2010; 31:1158-1163.
53. Nuovo GJ, Nakagawa H, Sotamaa K, de la Chapelle A. Hypermethylation of the MLH1 promoter with concomitant absence of transcript and protein occurs in small patches of crypt cells in unaffected mucosa from sporadic colorectal carcinoma. Diagn Mol Pathol 2006; 15:17-23.
54. Boudewijn JM, Braakhuis BJ, Maarten P, et al. A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res 2003; 63:1727-1730.
55. Waridel F, Estreicher A, Bron L, et al. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 1997; 14:163-169.
56. Park IW, Wistuba II, Maitra A, et al. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst 1999; 91:1863-1868.
57. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161:1051-1060.
58. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999; 59:4784-4787.